FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus
- Written by Annette Regan, Associate Professor of Epidemiology, University of San Francisco
Expecting parents and those with infants have new options to consider to protect against RSV.martin-dm/E+ via Getty ImagesWith the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to...

